Session 3: March 1, 2022 - 12:00 to 2:00 pm
In this three-session online course, participants will learn about the new science on the influence of environmental chemicals on cancer. The sessions are aimed at clinicians and also will be informative for policy makers, cancer researchers, and members of the public. Clinicians will be better able to answer patient questions, and they will gain skills in engaging in population-level policy change and community-based public health initiatives.
SESSION 3 DESCRIPTION
Primary prevention and a role for clinicians as trusted communicators - barriers and opportunities.
This activity is intended for clinicians & care providers from across all medical specialties.
Upon completion of this activity, participants will be able to:
- Demonstrate skills to speak with news media on impact of environmental issues on public health and cancer.
- Identify misinformation targeted to the public by industrial interests.
Dana-Farber Cancer Institute, DF/HCC Center for Cancer Equity and Engagement, Silent Spring Institute, UMass Lowell/Lowell Center for Sustainable Production, Cancer Free Economy Network & Mass General Brigham
March 1, 2022 | 12:00 - 2:00 PM ET
Session 3: Primary prevention and a role for clinicians as trusted communicators - barriers and opportunities.
Introduction: Forward-looking strategies to catalyze environmental cancer prevention.
- Julia Brody, PhD - Executive Director and Senior Scientist, Silent Spring Institute
- Margaret Kripke, PhD - Professor Emeritus and founding chair of the Department of Immunology at the University of Texas MD Anderson Cancer Center, Co-Panelist on the President’s Cancer Panel
- Missed opportunities for primary prevention of environmental cancers.
- David Michaels, PhD, MPH - George Washington University School of Public Health
- Author of The Triumph of Doubt on the challenge of defending public health science when it is targeted by chemical and drug makers sowing doubt.
- Ruthann Rudel, MS - Director of Research, Silent Spring Institute
- Chemicals that increase synthesis of estrogen and progesterone as risk factors for breast cancer: A case study for 21st century approaches to identifying likely carcinogens.
Panel: What to say to your patients, policymakers, and to the news media about chemicals and cancer when the science is uncertain.
- Moderator: Julia Brody
- Phil Landrigan, MD - Director, Global Public Health Program, Boston College
- Experiences of a pediatrician giving everyday advice and also speaking publicly about potential causes of cancer and other diseases without blaming patients.
- Amy Kostant, MA - Executive Director, Science Communication Network
- Practical guidance for scientists and clinicians to advance public understanding via the news media.
- Gary Ellison, PhD, MPH - National Institute of Environmental Health Sciences and National Cancer Institute
- New cohorts and other research to integrate environmental exposure and social determinants of health to advance equity.
Closing Remarks/Reflections: The role of cancer centers in advancing environmental prevention.
Julia Brody, PhD
Executive Director & Senior Scientist, Silent Spring Institute
Gary Ellison, PhD, MPH
Branch Chief, National Institute of Environmental Health Sciences & National Cancer Institute - Environmental Epidemiology
Amy Kostant, MA
Executive Director, Science Communication Network
Margaret Kripke, PhD
Professor Emeritus, and Founding Chair, University of Texas MD - Anderson Cancer Center, Department of Immunology
Phil Landrigan, MD, MSc
Director, Boston College - Global Public Health Program and Global Pollution Observatory
Chestnut Hill, MA
David Michaels, PhD, MPH
Professor, George Washington University School of Public Health
Author, "Doubt is Their Product"
Timothy Rebbeck, PhD
Vincent L. Gregory, Jr. Professor of Cancer Prevention
Director, Zhu Family Center for Global Cancer Prevention
Harvard T.H. Chan School of Public Health & Dana-Farber Cancer Institute
Ruthann Rudel, MS
Director of Research, Silent Spring Institute
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation Statement
2 Contact Hours of Nursing Continuing Professional Development (NCPD), will be awarded for attending each presentation in its entirety and completing an evaluation.
Dana-Farber Cancer Institute is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Nursing Contact Hours
- 2.00 Participation